Literature DB >> 6507460

Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980.

F L Ruben, C W Norden, Y Korica.   

Abstract

All 72 episodes of pneumococcal bacteremia from 1975 through 1980 at Montefiore Hospital, Pittsburgh, a medical/surgical hospital for adults, were reviewed. There were 10 to 14 episodes per year, accounting for 4 to 5 percent of all bacteremias; it was estimated that one episode occurred for every thousand patients discharged. Patients' ages ranged from 16 to 94 years (mean 61 years); 65 percent were male. There was an underlying disease in 87 percent of all patients, and 78 percent of the infections were community-acquired. Treatment with antimicrobial drugs was given to all but six patients. Overall mortality was 43 percent, but it was higher for asplenic patients (five of six died). In 44 percent of patients, one to four complications occurred. Outcome correlated with presence of coexisting disease (p less than 0.03), development of one or more complications (p less than 0.04), presence of asplenia (p = 0.04), and the type of antimicrobial treatment used (p less than 0.001; patients treated with penicillin alone fared better). Typing of isolates in the last two study years revealed that 67 percent of isolates were pneumococcal types present in 14-valent pneumococcal vaccine available at the time of the study. It is concluded that pneumococcal bacteremia occurs primarily in patients with underlying disease, and that pneumococcal vaccine should be offered to such patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6507460     DOI: 10.1016/0002-9343(84)90193-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Gram-Positive Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  Death rates among patients hospitalized with community-acquired pneumonia: a reexamination with data from three states.

Authors:  J S Markowitz; S Pashko; E M Gutterman; W T Linde-Zwirble; R Newbold
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

3.  S. pneumoniae: important contributor to morbidity and mortality in patients with chronic obstructive pulmonary disease--fact or fiction?

Authors:  A L Davis; C P Aranda; L C Christianson
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

4.  Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.

Authors:  J A Leech; A Gervais; F L Ruben
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

5.  Pneumococcal serotypes in sputum isolates during acute respiratory illness in Edinburgh.

Authors:  G A Gould; G B Rhind; A D Morgan; G Williamson; M A Calder
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

6.  Neutrophil responses to intravascular pneumococcal sonicate.

Authors:  C K Jutila; M A Jutila; R E Crowell; T W Chick; D E Van Epps; W P Reed
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

7.  Natural History of Francisella tularensis in Aerosol-Challenged BALB/c Mice.

Authors:  Henry S Heine; Lara Chuvala; Renaldo Riggins; Ryan Cirz; Robert Cass; Arnold Louie; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.